Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GVK Biosciences makes appointment

This article was originally published in Scrip

Executive Summary

GVK Biosciences, a contract research organisation, has appointed Professor Tarun Khanna to its board of directors. He is the Jorge Paulo Lemann Professor at the Harvard Business School, where he has been a member of the strategy group since 1993. Dr Khanna heads the strategy course in the Harvard MBA programme and the strategy, leadership and governance executive education programme. He also lectures and consults with companies and governments worldwide. Dr Khanna, who serves on the advisory boards of several multinational and emerging market companies, was nominated a Young Global Leader by the World Economic Forum in 2007.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC003260

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel